UBS Oconnor LLC

SEC CIK: 0001132716
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

LVTX holding history

LAVA Therapeutics NV in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LVTX overview All 13F holders of LVTX Full Q4 2025 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2022

Holdings of LVTX by UBS Oconnor LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−20,502−100.0%	Sold out	Holders
Q1 2023	20,502	$34.0K	<0.1%	+20,502	New	Holders
Q4 2022	0	$0	0.0%	−75,000−100.0%	Sold out	Holders
Q3 2022	75,000	$343.0K	<0.1%	+75,000	New	Holders